Laboratory testing for prader-willi syndrome

Management of Prader-Willi Syndrome: Third Edition

Volumn , Issue , 2006, Pages 74-93

  Monaghan, Kristin G ^a   Van Dyke, Daniel L ^b  

^a HENRY FORD HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960789121     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-33536-0_4     Document Type: Chapter

References (79)

1. ASHG/ACMG (American Society of Human Genetics/American College of Medical Genetics) Test and Technology Transfer Committee. Diagnostic testing for Prader-Willi and Angelman syndromes: report of the ASHG/ACMG Test and Technology Transfer Committee. American Journal of Human Genetics. 1996;58:1085-1088.
2. Baumer A, Wiedemann U, Hergersberg M, Schinzel A. A novel MSP/DHPLC method for the investigation of the methylation status of imprinting genes enables the molecular detection of low cell mosaicisms. Human Mutation. 2001;17:423-430.
3. Berend SA, Horwitz J, McCaskill C, Shaffer LG. Identification of uniparental disomy following prenatal detection of Robertsonian translocations and isochromosomes. American Journal of Human Genetics. 2000;66:1787-1793.
4. Buchholz T, Jackson J, Robson L, Smith A. Evaluation of methylation analysis for diagnostic testing in 258 referrals suspected of Prader-Willi or Angelman syndromes. Human Genetics. 1998;103:535-539.
5. Buchholz T, Jackson J, Smith A. Methylation analysis at three different loci within the imprinted region of chromosome 15q11-13. American Journal of Medical Genetics. 1997;72:117-119.
6. Buiting K, Dittrich B, Dworniczak B, et al. A 28-kb deletion spanning D15S63 (PW71) in five families: a rare neutral variant? American Journal of Human Genetics. 1999;65:1588-1594.
7. Buiting K, Dittrich B, Groß S, et al. Sporadic imprinting defects in Prader-Willi syndrome and Angelman syndrome: implications for imprint-switch models, genetic counseling, and prenatal diagnosis. American Journal of Human Genetics. 1998;63:170-180.
8. Buiting K, Farber C, Kroisel P, et al. Imprinting center deletions in two PWS families: implications for diagnostic testing and genetic counseling. Clinical Genetics. 2000;58:284-290.
9. Buiting K, Groß S, Lich C, Gillessen-Kaesbach G, El-Maarri O, Horsthemke B. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. American Journal of Human Genetics. 2003;72:571-577.
10. Buiting K, Saitoh S, Groß S, Dittrich B, Schwartz S, Nicholls RD, Horsthemke B. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting center on human chromosome 15. Nature Genetics. 1995;9:395-400.
11. Buller A, Pandya A, Jackson-Cook C, et al. Validation of a multiplex methylationsensitive PCR assay for the diagnosis of Prader-Willi and Angelman syndromes. Molecular Diagnosis. 2000;5:239-243.
12. Butler MG. Prader-Willi syndrome: current understanding of cause and diagnosis. American Journal of Medical Genetics. 1990;35:319-332.
13. Butler MG. Are specific short arm variants or heteromorphisms overrepresented in the chromosome 15 deletion in Angelman or Prader-Willi syndrome patients? American Journal of Medical Genetics. 1994;50:42-44.
14. Butler MG. Molecular diagnosis of Prader-Willi syndrome: comparison of cytogenetic and molecular genetic data including parent of origin dependent methylation DNA patterns. American Journal of Medical Genetics. 1996;61:188-190.
15. Butler MG, Christian SL, Kubota T, Ledbetter DH. A five year-old white girl with Prader-Willi syndrome and a submicroscopic deletion of chromosome 15q11-q13. American Journal of Medical Genetics. 1996;65:137-141.
16. Butler MG, Palmer CG. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet. 1983; I: 1285-1286.
17. Butler MG, Thompson T. Prader-Willi syndrome: clinical and genetic findings. The Endocrinologist. 2000;10:3S-16S.
18. Carrel AL, Huber S, Allen DB, Voelkerding KV. Assessment of SNRPN expression as a molecular tool in the diagnosis of Prader-Willi syndrome. Molecular Diagnosis. 1999;4:5-10.
19. Cassidy SB, Forsythe M, Heeger S, et al. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. American Journal of Medical Genetics. 1997;68:433-440.
20. Children's Health System and University of Washington, Seattle. The Gene Tests page. Available at: http://www.geneclinics.org. Accessed August 25, 2003.
21. Chotai KA, Payne SJ. A rapid, PCR-based test for the differential molecular diagnosis of Prader-Willi and Angelman syndromes. Journal of Medical Genetics. 1998;35:472-475.
22. Conroy JM, Grebe TA, Becker LA, et al. Balanced translocation 46, XY, t (2;15) (q37.2;q11.2) associated with atypical Prader-Willi syndrome. American Journal of Human Genetics. 1997;61:388-394.
23. Cuisset L, Vasseur C, Jeanpierre M, Delpech M, Noseda G, Ponsot, G. Potential pitfall in Prader-Willi syndrome and Angelman syndrome molecular diagnosis. American Journal of Medical Genetics. 1998;80:543-545.
24. Dittrich B, Buiting K, Groß S, Horsthemke B. Characterization of the methylation imprint in the Prader-Willi syndrome chromosome region. Human Molecular Genetics. 1993;2:1995-1999.
25. Dittrich B, Buiting K, Horsthemke B. PW71 methylation tests for Prader-Willi and Angelman syndromes. American Journal of Medical Genetics. 1996;61:196-197.
26. Dittrich B, Robinson WP, Knoblauch H, et al. Molecular diagnosis of the Prader-Willi and Angelman syndromes by detection of parent-oforigin specific DNA methylation in 15q11-q13. Human Genetics. 1992;90:313-315.
27. DKFZ Heidelburg, Germany. The Genome DataBase mirror site. Available at: http://www.gdb.org. Accessed October 30, 2003.
28. Fridman C, Varela MC, Kok F, Setian N, Koiffmann, CP. Prader-Willi syndrome: genetic tests and clinical findings. Genetic Testing. 2000;4(4):387-392.
29. Gillessen-Kaesbach G, Groß S, Kaya-Westerloh S, Passarge E, Horsthemke B. DNA methylation based testing of 450 patients suspected of having Prader-Willi syndrome. Journal of Medical Genetics. 1995;32:88-92.
30. Glatt K, Sinnett D, Lalande M. The human g-aminobutyric acid receptor subunit β3 and α5 gene cluster in chromosome 15q11-q13 is rich in highly polymorphic (CA) n repeats. Genomics. 1994;19:157-160.
31. Glenn CC, Deng G, Michaelis RC, et al. DNA methylation analysis with respect to prenatal diagnosis of the Angelman and Prader-Willi syndromes and imprinting. Prenatal Diagnosis. 2000;20:300-306.
32. Glenn CC, Porter KA, Jong M T C, Nicholls RD, Driscoll DJ. Functional imprinting and epigenetic modification of the human SNRPN gene. Human Molecular Genetics. 1993;2:2001-2005.
33. Glenn C, Saitoh S, Jong M T C, et al. Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. American Journal of Human Genetics. 1996;58:335-346.
34. Hawkey CJ, Smithies A. The Prader-Willi syndrome with a 15/15 translocation. Journal of Medical Genetics. 1976;13:152-156.
35. Herman E, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Science USA. 1996;93:9821-9826.
36. Horsthemke B, Nazlican H, Husing J, et al. Somatic mosaicism for maternal uniparental disomy 15 in a girl with Prader-Willi syndrome: confirmation by cell cloning and identification of candidate downstream genes. Human Molecular Genetics. 2003;12:2723-2732.
37. Hulten M, Armstrong S, Challinor P, et al. Genomic imprinting in an Angelman and Prader-Willi translocation family. Lancet. 1991;338:638-639.
38. Knoll J H M, Rogan PK. Sequence-based, in situ detection of chromosomal abnormalities at high resolution. American Journal of Medical Genetics. 2003;121A(3):245-257.
39. Kosaki K, McGinniss MJ, Veraksa AN, McGinnis WJ, Jones KL. Prader-Willi and Angelman syndromes: diagnosis with a bisulfite-treated methylationspecific PCR method. American Journal of Medical Genetics. 1997;73:308-313.
40. Kubota T, Aradhya S, Macha M, et al. Analysis of parent of origin specific DNA methylation at SNRPN and PW71 in tissues: implication for prenatal diagnosis. Journal of Medical Genetics. 1996;33:1011-1014.
41. Kubota T, Das S, Christian SL, Baylin SB, Herman JG, Ledbetter DH. Methylation-specific PCR simplifies imprinting analysis. Nature Genetics. 1997;16:16-17.
42. Kubota T, Sutcliffe JS, Aradhya S, et al. Validation studies of SNRPN methylation as a diagnostic test for Prader-Willi syndrome. American Journal of Medical Genetics. 1996;66:77-80.
43. Kuslich CD, Kobori JA, Mohapatra G, Gregorio-King C, Donlon TA. Prader-Willi syndrome is caused by disruption of the SNRPN gene. American Journal of Human Genetics. 1999;64:70-76.
44. Ledbetter DH, Engel E. Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. Human Molecular Genetics. 1995;4:1757-1764.
45. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. New England Journal of Medicine. 1981;304:325-329.
46. Lee MJ, Nishio H, Nagai T, Okamoto N, Yuki T, Sumino K. Molecular genetic analysis of the Prader-Willi syndrome using fluorescent multiplex PCR of dinucleotide repeats on chromosome 15q11-q13. Clinica Chimica Acta. 1998;271:89-96.
47. Lerer I, Meiner V, Pashut-Lavon I, Abeliovich D. Molecular diagnosis of Prader-Willi syndrome: parent of origin dependent methylation sites and non-isotopic detection of (CA) n dinucleotide repeat polymorphisms. American Journal of Medical Genetics. 1994;52:79-84.
48. Malzac P, Moncla A, Pedeillier K, Vo Van C, Girardot L, Voelckel MA. Atypical molecular findings identify limits of technical screening tests for Prader-Willi and Angelman syndrome diagnoses. American Journal of Medical Genetics. 1998;78:242-244.
49. Matin MM, Baumer A, Hornby DP. An analytical method for the detection of methylation differences at specific chromosomal loci using primer extension and ion pair reverse phase HPLC. Human Mutation. 2002;20:305-311.
50. McEntagart ME, Webb T, Hardy C, King MD. Familial Prader-Willi syndrome: case report and a literature review. Clinical Genetics. 2000;58:216-233.
51. Mignon C, Malzac P, Moncla A, et al. Clinical heterogeneity in 16 patients with inv dup 15 chromosome: cytogenetic and molecular studies, search for an imprinting effect. European Journal of Human Genetics. 1996;4:88-100.
52. Ming JE, Blagowidow N, Knoll J H M, et al. Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting. American Journal of Medical Genetics. 2000;92:19-24.
53. Monaghan KG, Wiktor A, Van Dyke DL. Diagnostic testing for Prader-Willi syndrome and Angelman syndrome: a cost comparison. Genetics in Medicine. 2002;44:448-450.
54. Muralidhar B, Butler MG. Methylation PCR analysis of Prader-Willi syndrome, Angelman syndrome, and control subjects. American Journal of Medical Genetics. 1998;80:263-265.
55. Mutirangura A, Greenberg F, Butler MG, et al. Multiplex PCR of three dinucleotide repeats in the Prader-Willi/Angelman critical region (15q11-q13): molecular diagnosis and mechanism of uniparental disomy. Human Molecular Genetics. 1993;2:143-151.
56. Nicholls RD, Knoll J H M, Butler MG, Karam S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndrome. Nature. 1989;342:281-284.
57. Ohta T, Gray TA, Rogan PK, et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. American Journal of Human Genetics. 1999;64:397-413.
58. Park JP, Moeschler JB, Hani VH, et al. Maternal disomy and Prader-Willi syndrome consistent with gamete complementation in a case of familial translocation (3;15) (p25;q11.2). American Journal of Medical Genetics. 1998;78:134-139.
59. Rineer S, Finucane B, Simon EW. Autistic symptoms among children and young adults with isodicentric chromosome 15. American Journal of Medical Genetics. 1998;81:428-433.
60. Robinson WP, Langlois S, Schuffenhauer S, et al. Cytogenetic and agedependent risk factors associated with uniparental disomy 15. Prenatal Diagnosis. 1996;16:837-844.
61. Robinson WP, Wagstaff J, Bernasconi F, et al. Uniparental disomy explains the occurrence of the Angelman or Prader-Willi syndrome in patients with an additional small inv dup (15) chromosome. Journal of Medical Genetics. 1993;30:756-760.
62. Rogan PK, Cazcarro P, Knoll J H M. Sequence-based design of single-copy genomic DNA probes for fluorescence in situ hybridization. Genome Research. 2001;11:1088-1094.
63. Schulze A, Hansen C, Skakkebaek NE, Brondum-Nielsen K, Ledbetter DH, Tommerup N. Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nature Genetics. 1996;12:452-454.
64. Silverstein S, Lerer I, Buiting K, Abeliovich D. The 28-kb deletion spanning D15S63 is a polymorphic variant in the Ashkenazi Jewish population. American Journal of Human Genetics. 2001;68:261-263.
65. Slater HR, Vaux C, Pertile M, Burgess T, Petrovic V. Prenatal diagnosis of Prader-Willi syndrome using PW71 methylation analysis-uniparental disomy and the significance of residual trisomy 15. Prenatal Diagnosis. 1997;17:109-113.
66. Smith A, Prasad M, Deng ZM, Robson L, Woodage T, Trent RJ. Comparison of high-resolution cytogenetics, fluorescence in situ hybridization, and DNA studies to validate the diagnosis of Prader-Willi and Angelman syndromes. Archives of Disease in Childhood. 1995;72:397-402.
67. Sun Y, Nicholls RD, Butler MG, Saitoh S, Hainline BE, Palmer CG. Breakage in the SNRPN locus in a balanced 46, XY, t (15;19) Prader-Willi syndrome patient. Human Molecular Genetics. 1996;5:517-524.
68. Sutcliffe JS, Nakao M, Christian S, et al. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nature Genetics. 1994;8:52-58.
69. Tenner KS, O'Kane DJ. Clinical application of Southern blot hybridiza - tion with chemiluminescence detection. Methods in Enzymology. 2000;305:450-466.
70. Tharapel AT, Kadandale JS, Martens PR, Wachtel SS, Wilroy RS, Jr. Prader Willi/Angelman and DiGeorge/Velocardiofacial syndrome deletions: diagnosis by primed in situ labeling (PRINS). American Journal of Medical Genetics. 2002;107:119-122.
71. Ungaro P, Christian SL, Fantes JA, et al. A molecular characterization of four cases of intrachromosomal triplication of chromosome 15q11-q14. Journal of Medical Genetics. 2001;38:26-34.
72. van den Ouweland A M W, van der Est MN, Wesby-van Swaay E, Tijmenson T S LN, Los FJ, Van Hemel JO. DNA diagnosis of Prader-Willi and Angelman syndromes with the probe PW71 (D15S63). Human Genetics. 1995;95:562-567.
73. Velinov M, Jenkins EC. PCR-based strategies for the diagnosis of Prader-Willi/Angelman syndromes. Methods and Molecular Biology. 2003;217:209-216.
74. Velinov M, Gu H, Genovese M, Duncan C, Brown WT, Jenkins E. The feasibility of PCR-based diagnosis of Prader-Willi and Angelman syndromes using restriction analysis after bisulfite modification of genomic DNA. Molecular Genetics and Metabolism. 2000;69:81-83.
75. Velinov M, Gu H, Shah K, et al. PCR-based methylation testing for Prader-Willi or Angelman syndromes using archived fixed-cell suspensions. Genetic Testing. 2001;5:153-155.
76. Wevrick R, Francke U. Diagnostic test for the Prader-Willi syndrome by SNRPN expression in blood. Lancet. 1996;348:1068-1069.
77. Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clinical Chemistry. 2001;47:1183-1189.
78. Zeschnigk M, Lich C, Buiting K, Doerfler W, Horsthemke B. A single-tube PCR test for the diagnosis of Angelman and Prader-Willi syndrome based on allelic methylation differences at the SNRPN locus. European Journal of Human Genetics. 1997;5:94-98.
79. Zeschnigk M, Schmitz B, Dittrich B, Buiting K, Horsthemke B, Doerfler W. Imprinted segments in the human genome: different DNA methylation patterns in the Prader-Willi/Angelman syndrome region as determined by the genomic sequencing method. Human Molecular Genetics. 1997;6:387-395.